| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Orlistat |
|---|
| Description | Orlistat is a cell-permeable, selective, and competitive lipase inhibitor (IC50 = 0.15 μM). Targets serine hydrolases in the nervous system, such as diacylglycerol lipase (DAGL), which is responsible for the conversion of DAG to 2-AG. Partially inhibits the hydrolysis of triglycerides and lowers the absorption of dietary fat, promoting weight loss. Promotes the sensitivity to TRAIL in cancer cells by ROS-mediated pathways. Displays antiobesity and antihypercholesterolemic activity in vivo. MW: 495.73. Purity ≥98% by HPLC |
|---|
| Size | 250 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N-Formyl-L-leucine (1S)-1-[[(2S, 3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester; Tetrahydrolipstatin |
|---|
| Gene, Accession, CAS # | CAS: 96829-58-2 |
|---|
| Catalog # | B1020-250 |
|---|
| Price | |
|---|
| Order / More Info | Orlistat from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|